Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2022-11-29 Director's Dealing
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Jung Byungyul) of Inventage Lab. This type of filing is a standard regulatory requirement for reporting insider transactions or changes in share ownership by company directors and executives, which corresponds to the 'Director's Dealing' category.
2022-11-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by Stassets Investment Corporation in Inventage Lab. This falls under the category of Major Shareholding Notification, as it tracks changes in significant ownership levels.
2022-11-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This type of filing is a standard regulatory requirement in South Korea for entities that acquire a significant stake (typically 5% or more) in a listed company. It details the reporting entity, the issuer, the number of shares held, and the purpose of the holding. This falls under the 'Major Shareholding Notification' category.
2022-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to disclose changes in shareholding by major shareholders or insiders. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ) as it details the ownership status and changes in holdings for a major shareholder (Smilegate Components & Materials Industry Investment Fund).
2022-11-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details the shareholding status of Stonebridge Ventures Inc. and its related funds in Inventage Lab. This type of filing is a standard regulatory requirement for entities crossing specific ownership thresholds, which falls under the 'Major Shareholding Notification' category.
2022-11-25 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by Inventage Lab. This document is a standard regulatory filing in South Korea (DART system) that details the final results of a public offering, including subscription amounts, allocation results, and the use of proceeds. It is not an announcement of a report, but the report itself. Among the provided categories, 'Share Issue/Capital Change' (SHA) is the most appropriate classification as it covers documents related to new share issues and capital changes resulting from public offerings.
2022-11-16 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.